Monday 06 October 2014 - Tuesday 07 October 2014
Venue: Weatherall Institute of Molecular Medicine - Oxford
Linking genetics and epigenetics will have major implications for our understanding of the development of many diseases, which may result from the co-action of genetic variations and epigenetic factors. The potentially reversible nature of epigenetic changes has made them a promising target for the development of novel medical treatments.
This workshop will explore the relationship between genome variants, gene expression and epigenetic mechanism and look at the implications of their interplay for diseases such as multiple sclerosis, asthma, neurological diseases and cancer.
We have secured a number of great speakers for this workshop:
The workshop will start at lunchtime on October 6th (registration and lunch from 11h30 – 12h45) and close in the afternoon of October 7th (around 16h30).
Venue: Weatherall Institute of Molecular Medicine, John Radcliffe Hospital/Headley Way, Oxford OX3 9DS, United Kingdom.
There will be a workshop supper on October 6th.
Please register as soon as possible as space is very limited! Registration fees and accommodation are covered by the EpiGeneSys Network, but all participants will be responsible for his/her own travel.
19-02-2015 - All News
Today special issue of Nature about the main findings of the NIH Roadmap Epigenomics Program, the aim of which was to systematically characterize epigenomic landscapes in primary human tissues and...
07-01-2015 - Science videos
"Epigenetic reprogramming in mammalian development" Wolf Reik, EpigeneSys member and at the head of the Epigenetics Programme, in the Babraham Institute in Cambridge gave a lecture the 16th of Ocktober 2014...